TOWER CELLX LIMITED
Company number 12819893 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£5,632
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-08-18
- Employees
- 0 (2025 accounts)
- Registered office
- 5 New Street Square, London, England, EC4A 3TW
- Postcode
- EC4A 3TW
- Capital
- 14 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-06-04
- Next due by
- 2027-06-18
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current
Robin Raihan, Professor ALI
Director
Andrew PEARSON
Director
Group structure
Controlled by TOWER THERAPEUTICS LIMITED — since 2020-08-18
From persons-with-significant-control filings on the public register.
Competitors London
This company ranks 52 among research and experimental development on biotechnology in London.
The class of 2020
40%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.